Almirall sights a "new era" of double-digit growth

Almirall's Chairman and CEO, Carlos Gallardo, has anticipated that the pharmaceutical company controlled by his family is entering a "new era" of double-digit growth and margin expansion. The group closed 2025 with earnings of 46.2 million euros, four times more than in 2024.